DMT study to progress investigations into TBI and stroke

Psych
Mon, Jun 5
Algernon NeuroScience (AGN Neuro) has announced that its Phase 1 DMT trial is complete. The company is now planning to accelerate into Phase 2 which will investigate DMT for the treatment of stroke...
Discover